RemeGen Co., Ltd. (SHA:688331)
China
· Delayed Price · Currency is CNY 61.61
+0.91 (1.50%)
Jun 27, 2025, 3:00 PM CST
RemeGen Market Cap
RemeGen has a market cap or net worth of 31.89 billion as of June 27, 2025. Its market cap has increased by 52.64% in one year.
Market Cap
31.89B
Enterprise Value
33.86B
Revenue
1.91B
Ranking
n/a
PE Ratio
n/a
Stock Price
61.61
Market Cap Chart
Since November 9, 2020, RemeGen's market cap has increased from 28.53B to 31.89B, an increase of 11.79%. That is a compound annual growth rate of 2.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2025 | 31.89B | 142.31% |
| Dec 31, 2024 | 13.16B | -53.43% |
| Dec 29, 2023 | 28.26B | -23.48% |
| Dec 30, 2022 | 36.93B | 18.81% |
| Dec 31, 2021 | 31.09B | -20.67% |
| Dec 31, 2020 | 39.18B | 37.36% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 344.23B |
| Shenzhen Mindray Bio-Medical Electronics | 274.10B |
| WuXi AppTec | 189.12B |
| Zhangzhou Pientzehuang Pharmaceutical., | 120.95B |
| Sichuan Biokin Pharmaceutical | 119.25B |
| Aier Eye Hospital Group | 115.27B |
| Shanghai United Imaging Healthcare | 105.13B |
| Yunnan Baiyao Group Co.,Ltd | 99.70B |